Katja Remlinger

778 total citations
19 papers, 610 citations indexed

About

Katja Remlinger is a scholar working on Epidemiology, Molecular Biology and Hepatology. According to data from OpenAlex, Katja Remlinger has authored 19 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 5 papers in Molecular Biology and 5 papers in Hepatology. Recurrent topics in Katja Remlinger's work include Hepatitis C virus research (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Hepatitis B Virus Studies (4 papers). Katja Remlinger is often cited by papers focused on Hepatitis C virus research (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Hepatitis B Virus Studies (4 papers). Katja Remlinger collaborates with scholars based in United States, United Kingdom and Australia. Katja Remlinger's co-authors include Shihyun You, Robert Hamatake, Andrew Baillie, Michael J. McGarvey, Marc K. Hellerstein, Stephen A. Stimpson, William J. Evans, Lisa G. Clifton, Scott Turner and Todd Shearer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Endocrine Reviews.

In The Last Decade

Katja Remlinger

19 papers receiving 603 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katja Remlinger United States 13 207 179 136 129 99 19 610
Lu-Wen Wang China 19 342 1.7× 267 1.5× 72 0.5× 156 1.2× 124 1.3× 48 916
Li Zhong China 17 375 1.8× 278 1.6× 72 0.5× 121 0.9× 65 0.7× 50 890
Katarzyna Gawlik Poland 16 185 0.9× 116 0.6× 88 0.6× 87 0.7× 37 0.4× 36 632
Rajesh Kumar Dutta United States 14 271 1.3× 215 1.2× 59 0.4× 61 0.5× 81 0.8× 21 616
Kyoko Tomita Japan 16 304 1.5× 340 1.9× 61 0.4× 184 1.4× 101 1.0× 32 772
Traci E. Stankiewicz United States 12 172 0.8× 371 2.1× 154 1.1× 73 0.6× 193 1.9× 22 686
Emily O’Neill United States 7 145 0.7× 158 0.9× 56 0.4× 114 0.9× 188 1.9× 13 624
Christoph Elsing Germany 18 329 1.6× 182 1.0× 184 1.4× 112 0.9× 124 1.3× 47 1.1k
Mashiko Setshedi South Africa 14 236 1.1× 441 2.5× 104 0.8× 112 0.9× 40 0.4× 40 1.0k
Yoshiyasu Shinohara Japan 11 217 1.0× 451 2.5× 139 1.0× 129 1.0× 45 0.5× 18 665

Countries citing papers authored by Katja Remlinger

Since Specialization
Citations

This map shows the geographic impact of Katja Remlinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katja Remlinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katja Remlinger more than expected).

Fields of papers citing papers by Katja Remlinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katja Remlinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katja Remlinger. The network helps show where Katja Remlinger may publish in the future.

Co-authorship network of co-authors of Katja Remlinger

This figure shows the co-authorship network connecting the top 25 collaborators of Katja Remlinger. A scholar is included among the top collaborators of Katja Remlinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katja Remlinger. Katja Remlinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Kazmierski, Wieslaw M., George M. Adjabeng, Richard M. Grimes, et al.. (2020). GSK2818713, a Novel Biphenylene Scaffold-Based Hepatitis C NS5A Replication Complex Inhibitor with Broad Genotype Coverage. Journal of Medicinal Chemistry. 63(8). 4155–4170. 7 indexed citations
2.
McKnight, Kevin L., Karen V. Swanson, Kathryn Austgen, et al.. (2020). Stimulator of interferon genes (STING) is an essential proviral host factor for human rhinovirus species A and C. Proceedings of the National Academy of Sciences. 117(44). 27598–27607. 29 indexed citations
3.
Washburn, Michael L., Zhang Wang, Andrew H. Walton, et al.. (2019). T Cell– and Monocyte-Specific RNA-Sequencing Analysis in Septic and Nonseptic Critically Ill Patients and in Patients with Cancer. The Journal of Immunology. 203(7). 1897–1908. 38 indexed citations
4.
Washburn, Michael L., et al.. (2019). Therapeutically Attenuating Neutrophil Recruitment With a CXCR2 Antagonist in Combination With Oseltamivir Ameliorates Influenza-Induced Lung Injury and Disease. Open Forum Infectious Diseases. 6(4). ofz106–ofz106. 12 indexed citations
5.
Chakravorty, Subhas J., James L. Chan, Katja Remlinger, et al.. (2018). Nuisance Compounds, PAINS Filters, and Dark Chemical Matter in the GSK HTS Collection. SLAS DISCOVERY. 23(6). 532–544. 43 indexed citations
6.
Patel, Keyur, Katja Remlinger, Peter Leitner, et al.. (2014). Multiplex Protein Analysis to Determine Fibrosis Stage and Progression in Patients With Chronic Hepatitis C. Clinical Gastroenterology and Hepatology. 12(12). 2113–2120.e3. 26 indexed citations
7.
8.
Voitenleitner, Christian, Renae M. Crosby, Katja Remlinger, et al.. (2013). In Vitro Characterization of GSK2485852, a Novel Hepatitis C Virus Polymerase Inhibitor. Antimicrobial Agents and Chemotherapy. 57(11). 5216–5224. 10 indexed citations
9.
Crosby, Renae M., Amy Wang, Jessica Vamathevan, et al.. (2013). Preclinical Characterization of GSK2336805, a Novel Inhibitor of Hepatitis C Virus Replication That Selects for Resistance in NS5A. Antimicrobial Agents and Chemotherapy. 58(1). 38–47. 20 indexed citations
10.
Stimpson, Stephen A., Michael S. Leonard, Lisa G. Clifton, et al.. (2013). Longitudinal determination of total body creatine pool size and skeletal muscle mass in rats by D 3 ‐creatine dilution. The FASEB Journal. 27(S1). 1 indexed citations
11.
Stimpson, Stephen A., Michael S. Leonard, Lisa G. Clifton, et al.. (2013). Longitudinal changes in total body creatine pool size and skeletal muscle mass using the D3‐creatine dilution method. Journal of Cachexia Sarcopenia and Muscle. 4(3). 217–223. 51 indexed citations
12.
Stimpson, Stephen A., Scott Turner, Lisa G. Clifton, et al.. (2012). Total-body creatine pool size and skeletal muscle mass determination by creatine-(methyl-d3) dilution in rats. Journal of Applied Physiology. 112(11). 1940–1948. 55 indexed citations
13.
Rong, James X., Yang Qiu, Jennifer H. Johnson, et al.. (2011). Rosiglitazone Induces Mitochondrial Biogenesis in Differentiated Murine 3T3-L1 and C3H/10T1/2 Adipocytes. PPAR Research. 2011. 1–11. 35 indexed citations
14.
Gentry, Daniel R., Katja Remlinger, C A Richards, et al.. (2010). A rapid microtiter plate assay for measuring the effect of compounds on Staphylococcus aureus membrane potential. Journal of Microbiological Methods. 83(2). 254–256. 24 indexed citations
15.
Chen, Lihong, Judi A. McNulty, Don L. Anderson, et al.. (2010). Cholestyramine Reverses Hyperglycemia and Enhances Glucose-Stimulated Glucagon-Like Peptide 1 Release in Zucker Diabetic Fatty Rats. Journal of Pharmacology and Experimental Therapeutics. 334(1). 164–170. 66 indexed citations
16.
17.
Alaynick, William A., James M. Way, William G. Benson, et al.. (2009). ERRγ Regulates Cardiac, Gastric, and Renal Potassium Homeostasis. Molecular Endocrinology. 24(2). 299–309. 62 indexed citations
18.
Alaynick, William A., James M. Way, William G. Benson, et al.. (2009). ERRγ Regulates Cardiac, Gastric, and Renal Potassium Homeostasis. Endocrine Reviews. 30(7). 931–931. 1 indexed citations
19.
Degenhardt, Yan, Katja Remlinger, Joel Greshock, et al.. (2006). Biomarker analyses of PLK isoforms in breast cancer. Cancer Research. 66. 459–459. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lu-Wen Wang Breakdown of academic impact, for papers by Li Zhong Breakdown of academic impact, for papers by Katarzyna Gawlik Breakdown of academic impact, for papers by Rajesh Kumar Dutta Breakdown of academic impact, for papers by Kyoko Tomita Breakdown of academic impact, for papers by Traci E. Stankiewicz Breakdown of academic impact, for papers by Emily O’Neill Breakdown of academic impact, for papers by Christoph Elsing Breakdown of academic impact, for papers by Mashiko Setshedi Breakdown of academic impact, for papers by Yoshiyasu Shinohara
Rankless by CCL
2026